Latest News

Samumed’s Experimental Drug Initial Results Show Effective Bald Treatment

Samumed’s Experimental Drug Initial Results Show Effective Bald Treatment

A presentation to the American Academy of Dermatology in Washington, D.C. has shown that an experimental drug from Samumed, an unknown San-Diego-based biotechnology firm, is efficient in growing hair among bald men. The preliminary data, delivered by Yusuf Yazici, Samumed Chief Medical Officer, have demonstrated ‘promising’ results. However, there are many concerns whether the drug will hold up in larger[Read More…]

by October 18, 2016
GlaxoSmithKline Plc (NYSE:GSK) to Publish LABA Safety Study Results on NEJM

GlaxoSmithKline Plc (NYSE:GSK) to Publish LABA Safety Study Results on NEJM

GlaxoSmithKline Plc (ADR) (NYSE:GSK) has revealed that the results from thelong acting beta2-agonist (LABA) safety study of AdvairDiskus, AUSTRI (SAS115359), will be published in the New England Journal of Medicine (NEJM). The results were initially reported in October by GSK. Simultaneously, the results of the said study are presented at the annual meeting of the American Academy of Asthma, Allergy,[Read More…]

by October 17, 2016
Anti-Shkreli Mathai Mammen Assumes A Senior Role At Merck & Co., Inc. (NYSE:MRK)

Anti-Shkreli Mathai Mammen Assumes A Senior Role At Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (NYSE:MRK) has welcomed Mathai Mammen–one the pharma industry’s champions and who has more often than not been described as the “anti-Shkreli” to its executive team. The founder of Theravance Biopharma Inc (NASDAQ:TBPH) in 1996 and where he has served as senior vice president of R&D will now assume a prominent role in charge of significant portions[Read More…]

by October 14, 2016
HHS’ Wall of Shame Does Little in Shaming

HHS’ Wall of Shame Does Little in Shaming

When healthcare information are breached and compromised, healthcare organizations are tasked to report such incident to the US Department of Health and Human Services (HHS) Office of Civil Rights, which is tasked to. When 500 or more records are involved, the HHS Office of Civil Rights must publicly post it on its official website, which is dubbed as the “wall[Read More…]

by October 13, 2016